PNV 3.57% $2.43 polynovo limited

Ann: Webcast Recording for FY24 Results Presentation, page-9

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 74 Posts.
    lightbulb Created with Sketch. 17
    The only disappointing issue I had with the presentation was the comment on capital management. I interpreted DW' as "no dividend for the foreseeable future".

    I found this curious given:-
    • low capital requirement for manufacture
    • high product margin (evidence seems to be that this is maintainable)
    • business profitable
    • sales growing at a fantastic rate and which will largely drop to bottom line
    • modest r+d spend
    • innovative usage being lead/supported by growing surgical community
    • being "dragged into markets" by growing surgical community

    I understand the benefits of growing market and understand DW's comments about paying yourself a div by selling the odd share. However, I would have appreciated the board's confidence by indicating that a div is in the offing. I think that would ignite the share price, improving the currency for future acquisitions as alluded to by DW.

    Am I missing something? I know it's only a minor given the company's growth trajectory, and I'll continue slowly accumulating on SP weakness
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.